Tenaya Therapeutics, Inc. (TNYA)
NASDAQ: TNYA · Real-Time Price · USD
2.410
+0.470 (24.23%)
At close: Nov 4, 2024, 4:00 PM
2.430
+0.020 (0.83%)
After-hours: Nov 4, 2024, 7:59 PM EST
Tenaya Therapeutics Employees
Tenaya Therapeutics had 140 employees as of December 31, 2023. The number of employees decreased by 1 or -0.71% compared to the previous year.
Employees
140
Change (1Y)
-1
Growth (1Y)
-0.71%
Revenue / Employee
n/a
Profits / Employee
-$862,407
Market Cap
190.12M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 140 | -1 | -0.71% |
Dec 31, 2022 | 141 | 35 | 33.02% |
Dec 31, 2021 | 106 | 31 | 41.33% |
Dec 31, 2020 | 75 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Repare Therapeutics | 179 |
Adverum Biotechnologies | 121 |
EUDA Health Holdings | 106 |
Lineage Cell Therapeutics | 75 |
Vigil Neuroscience | 69 |
Compugen | 68 |
Galectin Therapeutics | 14 |
Actuate Therapeutics | 5 |
TNYA News
- 18 days ago - Tenaya Therapeutics Announces Updates on TN-201 Gene Therapy Program for MYBPC3-associated HCM - GlobeNewsWire
- 2 months ago - Tenaya Therapeutics to Participate in Upcoming Investment Conferences - GlobeNewsWire
- 4 months ago - Tenaya Therapeutics Announces Research Leadership Updates - GlobeNewsWire
- 4 months ago - Tenaya Therapeutics to Participate at the TD Cowen Genetic Medicines & RNA Summit - GlobeNewsWire
- 6 months ago - Tenaya Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Tenaya Therapeutics to Highlight Growing Capabilities in Capsid Engineering, Gene Editing and Manufacturing at the American Society of Gene and Cell Therapy 27th Annual Meeting - GlobeNewsWire
- 8 months ago - Tenaya Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 8 months ago - Tenaya Therapeutics Announces Publication of TN-401 Gene Therapy Preclinical Data in Nature Communications Medicine - GlobeNewsWire